{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:00:59Z","timestamp":1782176459977,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejso.2022.08.031","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T06:16:00Z","timestamp":1661926560000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-6369","authenticated-orcid":false,"given":"Mehdi","family":"Boubaddi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-2655","authenticated-orcid":false,"given":"Christina","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Frulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Salut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-5244","authenticated-orcid":false,"given":"Quentin","family":"Denost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.08.031_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.08.031_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.08.031_bib4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S1470-2045(15)00215-6","article-title":"Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/DCR.0000000000001338","article-title":"Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: it may take longer than you think","volume":"62","author":"Habr-Gama","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2022.08.031_bib6","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13063-017-2085-2","volume":"18","author":"Battersby","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.ejso.2022.08.031_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41571-021-00538-5","article-title":"International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer","volume":"18","author":"Fokas","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib10","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.2011.34.9068","article-title":"Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience","volume":"29","author":"Patel","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib11","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1245\/s10434-012-2309-3","article-title":"Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer","volume":"19","author":"Patel","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib12","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1245\/s10434-018-6738-5","article-title":"Robotic versus laparoscopic total mesorectal excision for sphincter-saving surgery: results of a single-center series of 400 consecutive patients and perspectives","volume":"25","author":"Rouanet","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/codi.15598","article-title":"Let\u2019s talk about sex\u201d: a patient-led survey on sexual function after colorectal and pelvic floor surgery","volume":"23","author":"Dames","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2022.08.031_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/codi.15416","article-title":"Association between urinary function and resected pattern of the autonomic nerve system after transanal total mesorectal excision for rectal cancer","volume":"23","author":"Shiraishi","year":"2021","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2022.08.031_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12893-021-01166-7","article-title":"Permanent stoma: a quality outcome in treatment of rectal cancer and its impact on length of stay","volume":"21","author":"Lemini","year":"2021","journal-title":"BMC Surg"},{"key":"10.1016\/j.ejso.2022.08.031_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.08.031_bib17","doi-asserted-by":"crossref","first-page":"djw171","DOI":"10.1093\/jnci\/djw171","article-title":"Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer","volume":"108","author":"Martens","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2022.08.031_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019474","article-title":"Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study","volume":"7","author":"Rombouts","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2022.08.031_bib19","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2005.06.114","article-title":"Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point","volume":"23","author":"Guillem","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2503080310","article-title":"Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy","volume":"250","author":"Barbaro","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2022.08.031_bib21","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib22","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.3748\/wjg.v22.i37.8414","article-title":"Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales","volume":"22","author":"Siddiqui","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2022.08.031_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2014.11.026","article-title":"The role of diffusion-weighted MRI and (18)F-FDG PET\/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review","volume":"113","author":"Joye","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib24","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s00330-005-2658-4","article-title":"Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?","volume":"15","author":"Denecke","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2022.08.031_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1245\/s10434-017-6213-8","article-title":"Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near-complete response?","volume":"25","author":"Hupkens","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib26","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.08.031_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.08.031_bib28","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2020.38.15_suppl.4008","article-title":"Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial","volume":"38","author":"Garcia-Aguilar","year":"2020","journal-title":"J\u00a0Clin Oncology"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:01Z","timestamp":1760060821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0748798322006424"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.031","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}